De Novo Darbepoetin alfa Treatment Administered Every Other Week (Q2W) Corrects and Maintains Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD)
Krause M, Raja R, Agarwal A, Silver MR, Scarlata D, Sciarra A, Audhya P. De Novo Darbepoetin alfa Treatment Administered Every Other Week (Q2W) Corrects and Maintains Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD). 2007.